суббота, 11 марта 2017 г.

Jefferies Group Brokers Increase Earnings Estimates for Spectrum Pharmaceuticals, Inc.

Jefferies Group Brokers Increase Earnings Estimates for Spectrum Pharmaceuticals, Inc.


Spectrum Pharmaceuticals, Inc. - Investment analysts at Jefferies Group lifted their FY2020 EPS estimates for shares of Spectrum Pharmaceuticals in a report issued on Thursday. Jefferies Group analyst M. Andrews now anticipates that the brokerage will post earnings of $0.60 per share for the year, up from their previous estimate of $0.49.



from Biotech News